BioXcel Therapeutics Announces Pricing of $7.0 Million Public …
NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, …
OFF
BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …
6 days from now
NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, …
bioxceltherapeutics.com
OFF
BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …
6 days from now
21 hours ago · NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing …
yahoo.com
OFF
BTAI - BioXcel Therapeutics Announces Pricing Of $7.0...
6 days from now
NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced the pricing of an underwritten public offering of 5,600,000 shares of its common …
marketwirenews.com
OFF
BioXcel Therapeutics Announces Pricing Of $7M Public Offering
6 days from now
BioXcel Therapeutics, Inc. (BTAI) Q3 2024 Earnings Call Transcript BioXcel announces common stock and warrants offering, no amount given BioXcel Therapeutics GAAP EPS of -$0.32 …
msn.com
OFF
BioXcel Therapeutics Announces Pricing Of $7M Public Offering
6 days from now
20 hours ago · BioXcel Therapeutics announces pricing of public offering at $0.48 per share, grossing $7 million. ... BTAI) on Friday announced the pricing of an underwritten public offering …
seekingalpha.com
OFF
BioXcel Therapeutics Prices 5.6M Shares At 48c In Public Offering
6 days from now
1 day ago · BioXcel Therapeutics (BTAI) announced the pricing of an underwritten public offering of 5,600,000 shares of its common stock, par value $0.001 per share and accompanying …
businessinsider.com
OFF
BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …
6 days from now
1 day ago · NEW HAVEN, Conn., Nov. 22, 2024 -- BioXcel Therapeutics, Inc. , a biopharmaceutical company utilizing artificial intelligence approaches to develop …
marketscreener.com
OFF
BioXcel Therapeutics Announces Pricing Of $7.0 Million
6 days from now
21 hours ago · NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing …
globenewswire.com
OFF
BioXcel Therapeutics Prices Of $7 Million Public Offering
6 days from now
1 day ago · NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence approaches to …
citybiz.co
OFF
BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …
6 days from now
21 hours ago · BioXcel Therapeutics (BTAI) has announced the pricing of a $7.0 million public offering, consisting of 5,600,000 shares of common stock and warrants to purchase up to …
stocktitan.net
OFF
BioXcel Therapeutics (BTAI) Announces Pricing Of $7.0 Million …
6 days from now
21 hours ago · BioXcel Therapeutics (BTAI) Announces Pricing of $7.0 Million Public Offering Article Related Press Releases ( 1 ) Stock Quotes (1) FREE Breaking News Alerts from …
streetinsider.com
OFF
BioXcel Therapeutics Announces Pricing Of $7.0 Million Public Of
6 days from now
NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the â Companyâ ) ( BTAI), a biopharmaceutical company utilizing artificial i 🚀 Enjoy a 7-Day Free …
gurufocus.com
OFF
2024-11-22 | BioXcel Therapeutics Announces Pricing Of $7.0 …
6 days from now
1 day ago · NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company …
stockhouse.com
OFF
BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …
6 days from now
NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the "Company") (NASDAQ:BTAI), a biopharmaceutical company utilizing artificial intelligence …
quantisnow.com
OFF
BioXcel Therapeutics Announces Pricing Of $7.0 Million Public …
6 days from now
20 hours ago · NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the "Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing …
manilatimes.net
OFF
BioXcel Therapeutics Reports Third Quarter 2024 Financial Results
6 days from now
Nov 14, 2024 · NetLoss: BioXcel Therapeutics had a net loss of $13.7 million for the third quarter of 2024, compared to a net loss of $50.5 million for the same period in 2023. The Company …
businessinsider.com
OFF
BioXcel Therapeutics Announces Pricing Of $7.0 Million Public
6 days from now
BTAI BioXcel Therapeutics Inc BioXcel Therapeutics Announces Pricing of $7.0 Million Public Offering. NEW HAVEN, Conn., Nov. 22, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, …
advfn.com
FAQs about BioXcel Therapeutics Announces Pricing of $7.0 Million Public … Coupon?
Who owns bioxcel Therapeutics (btai)?
Is bioxcel Therapeutics a biopharmaceutical company?
What time will bioxcel Therapeutics' financial results be released?
How much cash did bioxcel Therapeutics use in third quarter 2024?
How do I contact bioxcel Therapeutics?
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
